New FDA approval for adalimumab: Hidradenitis suppurativa

The approval of adalimumab has been expanded to include the treatment of moderate to severe hidradenitis suppurativa. Approval is based on the results of two phase III studies, PIONEER Iand <a...
Source: Skin and Allergy News - Category: Dermatology Source Type: news